Gervais A, Martinot M, Boyer N, Auperin A, Le Breton W, Degott C, Valla D, Marcellin P
Service d'Hépatologie, Centre de Recherche Claude Bernard sur les Hépatites Virales, Hĵpital Beaujon AP-HP, Clichy, France.
J Hepatol. 2001 Sep;35(3):399-405. doi: 10.1016/s0168-8278(01)00138-6.
BACKGROUND/AIMS: To determine the correlation between hepatic hepatitis C virus (HCV) RNA and histological lesions, viral genotype or response to alpha interferon therapy.
Forty-three patients with chronic hepatitis C (14 sustained responders (SR) and 29 non-sustained responders (NSR)) were studied. A liver tissue sample was obtained before and 1 year after treatment. Quantitation of hepatic HCV-RNA was performed by competitive PCR.
Before treatment, HCV-RNA was detectable in all liver samples. There was no association between hepatic HCV-RNA and the severity of liver lesions. There was a significant association between old age and hepatic HCV-RNA (P = 0.03). There was an association, at the limit of significance, between genotype 1 and high hepatic HCV-RNA amounts (15 x 106 and 4.1 x 10(6) copies/g, P = 0.05). Pre-treatment hepatic HCV-RNA amounts were lower in SRs than in others (0.65 x 10(6) and 13.2 x 10(6) copies/g, P = 0.0002). After treatment, no liver HCV-RNA was detectable in the SRs while in the NSRs, the HCV-RNA amounts were unchanged.
The amount of hepatic HCV-RNA is correlated to genotype and response to interferon therapy but not to histologic lesions. Hepatic HCV-RNA clearance is observed in SRs, suggesting viral eradication.
背景/目的:确定肝内丙型肝炎病毒(HCV)RNA与组织学病变、病毒基因型或α干扰素治疗反应之间的相关性。
对43例慢性丙型肝炎患者(14例持续应答者(SR)和29例非持续应答者(NSR))进行研究。在治疗前及治疗1年后获取肝组织样本。采用竞争性PCR对肝内HCV-RNA进行定量分析。
治疗前,所有肝组织样本中均能检测到HCV-RNA。肝内HCV-RNA与肝损伤严重程度之间无关联。年龄与肝内HCV-RNA之间存在显著关联(P = 0.03)。基因型1与高肝内HCV-RNA量(15×10⁶和4.1×10⁶拷贝/克)之间存在显著关联(P = 0.05)。SR组治疗前肝内HCV-RNA量低于其他组(0.65×10⁶和13.2×10⁶拷贝/克,P = 0.0002)。治疗后,SR组肝内未检测到HCV-RNA,而NSR组HCV-RNA量未改变。
肝内HCV-RNA量与基因型及干扰素治疗反应相关,但与组织学病变无关。在SR组观察到肝内HCV-RNA清除,提示病毒被根除。